DGM

Darwin Global Management Portfolio holdings

AUM $2.38B
1-Year Est. Return 81.43%
This Quarter Est. Return
1 Year Est. Return
+81.43%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$655M
AUM Growth
+$111M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
17
New
Increased
Reduced
Closed

Top Buys

1
+$455M
2
+$29.8M
3
+$12.4M
4
KROS icon
Keros Therapeutics
KROS
+$6.52M
5
CCXI
ChemoCentryx, Inc.
CCXI
+$5.89M

Top Sells

1
+$344M
2
+$17.3M
3
+$11.9M
4
FATE icon
Fate Therapeutics
FATE
+$11.7M
5
BNTX icon
BioNTech
BNTX
+$11.1M

Sector Composition

1 Healthcare 99.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$455M 69.44%
+7,697,762
2
$71.6M 10.94%
605,587
-146,437
3
$29.8M 4.56%
+511,908
4
$25.9M 3.95%
591,975
+49,389
5
$23.2M 3.55%
90,057
-42,875
6
$12.4M 1.9%
+166,190
7
$8.98M 1.37%
153,537
-199,713
8
$6.52M 1%
+111,500
9
$6.11M 0.93%
145,841
+100,530
10
$5.89M 0.9%
+161,802
11
$5.62M 0.86%
317,428
+283,431
12
$3.14M 0.48%
216,143
+56,750
13
$852K 0.13%
23,104
-4,293
14
– –
-357
15
– –
-253,692
16
– –
-86,528
17
– –
-2,000,000